Palantir Technologies, founded in 2004 and based in the United States, operates within the software industry, specifically focusing on security software and information technology services. The company employs between 1,001 and 5,000 individuals and reported revenue of approximately $4.15 billion. Palantir collaborates with a range of organizations, including pharmaceutical companies, health regulators, public health services, and research institutions, to enhance data-driven research and operational efficiency. Its published documents highlight the challenges and advancements in pharmaceutical research, particularly in the context of COVID-19 vaccine development. The company emphasizes the importance of integrating human expertise with advanced computational technologies to drive novel scientific insights. Additionally, Palantir's solutions, such as the Foundry platform, are designed to synchronize multi-functional research efforts, reflecting the increasing complexity and specialization of scientific collaboration. The company’s work illustrates a commitment to transforming individual expertise into institutional knowledge, addressing the evolving demands of research environments through digital transformation.